CapiScan key facts
- Operator of a capillary refill time monitoring device intended to provide objective assessment of tissue perfusion in critical care.
- Notable investors include Thematic Technology Transfer.
- Status: Privately Held (backing).
Who backs CapiScan
1- ·Watch CapiScan: the Monday email on marks, rounds and moves
CapiScan funding rounds
No funding rounds for CapiScan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CapiScan investors
1 investor is on record for CapiScan, including Thematic Technology Transfer.
About CapiScan
Operator of a capillary refill time monitoring device intended to provide objective assessment of tissue perfusion in critical care. The company offers a sensor-based monitoring device with standardized measurement and portable design, enabling healthcare providers in intensive care settings improve perfusion assessment and support timely treatment decisions.
- Sector
- Healthcare
- HQ
- Enschede, Netherlands
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CapiScan doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.